Oxford BioMedica accelerates viral vector development and manufacture
(Alliance News) - Oxford Biomedica PLC on Monday announced the launch of fast-track offering for adeno-associated viral vectors and lentiviral vector platforms. Read More
| Price | 657.00p on 21-04-2026 at 09:49:44 |
|---|---|
| Change | 13.00p 2.02% |
| Buy | 658.00p |
| Sell | 656.00p |
| Last Trade: | Unknown 0.00 at 657.00p |
| Day's Volume: | 100,246 |
| Last Close: | 644.00p |
| Open: | 644.00p |
| ISIN: | GB00BDFBVT43 |
| Day's Range | 640.00p - 657.00p |
| 52wk Range: | 270.50p - 950.00p |
| Market Capitalisation: | £794.31m |
| VWAP: | 649.17845p |
| Shares in Issue: | 120.90m |
Oxford Biomedica (OXB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 0 | 657.00p | SI Trade |
10:49:44 - 21-Apr-26 |
| Buy* | 65 | 657.00p | Automatic Execution |
10:49:44 - 21-Apr-26 |
| Buy* | 83 | 657.00p | Automatic Execution |
10:49:44 - 21-Apr-26 |
| Buy* | 186 | 657.00p | Automatic Execution |
10:49:44 - 21-Apr-26 |
| Buy* | 300 | 657.00p | Automatic Execution |
10:49:44 - 21-Apr-26 |
| Sell* | 144 | 656.00p | Automatic Execution |
10:45:09 - 21-Apr-26 |
| Sell* | 29 | 656.00p | Automatic Execution |
10:44:57 - 21-Apr-26 |
| Sell* | 312 | 656.00p | Automatic Execution |
10:44:44 - 21-Apr-26 |
| Sell* | 116 | 656.00p | Automatic Execution |
10:44:35 - 21-Apr-26 |
| Sell* | 6 | 656.00p | Automatic Execution |
10:44:35 - 21-Apr-26 |
Oxford Biomedica (OXB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Apr 2026 7:00 am | RNS-R | Launch of viral vector fast-track offering |
| 8th Apr 2026 5:18 pm | RNS | Grant of Awards |
| 1st Apr 2026 7:00 am | RNS | Total Voting Rights |
| 30th Mar 2026 3:30 pm | RNS | 2026 Annual General Meeting notification |
| 26th Mar 2026 7:00 am | RNS | Preliminary results for the year ended 31 Dec 2025 |
| 18th Mar 2026 7:00 am | RNS-R | Licensing agreement with VVMF |
| 9th Mar 2026 7:53 am | RNS | Admission to Trading |
| 4th Mar 2026 11:45 am | RNS | Admission to Trading Application |
| 3rd Mar 2026 7:00 am | RNS | Capital Markets Day and investor conferences |
| 2nd Mar 2026 7:00 am | RNS | Total Voting Rights |